Deutsche Märkte öffnen in 6 Stunden 59 Minuten

Medtronic plc (2M6.DE)

XETRA - XETRA Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
108,15-1,05 (-0,96%)
Börsenschluss: 5:35PM MESZ

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
http://www.medtronic.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter90.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Geoffrey Straub MarthaCEO & Chairman1,68MN/A1970
Ms. Karen L. ParkhillExec. VP & CFO1,81MN/A1965
Mr. Bradley E. LermanSr. VP, Gen. Counsel & Corp. Sec.1,74MN/A1956
Mr. Mark PloofSr. VP of Global Operations and Bus. ServicesN/AN/AN/A
Ms. Jennifer M. KirkPrincipal Accounting Officer, Global Controller & Chief Accounting OfficerN/AN/A1975
Dr. Richard E. KuntzSr. VP & Chief Medical and Scientific OfficerN/AN/A1957
Mr. Sean LennonChief Information OfficerN/AN/AN/A
Mr. Ryan WeispfenningVP of Investor RelationsN/AN/AN/A
Ms. Marguerite CopelPR & Interim Chief Communications OfficerN/AN/AN/A
Ms. Carol A. SurfaceSr. VP & Chief HR OfficerN/AN/A1966
Die Beträge haben den Stand 31. Dezember 2020 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Corporate Governance

Medtronic plcs ISS Governance QualityScore, Stand 1. Juli 2021, lautet 6. Die grundlegenden Scores sind Audit: 7, Vorstand: 8, Shareholderrechte: 6, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.